Lionel Ades

Lionel Ades

UNVERIFIED PROFILE

Are you Lionel Ades?   Register this Author

Register author
Lionel Ades

Lionel Ades

Publications by authors named "Lionel Ades"

Are you Lionel Ades?   Register this Author

100Publications

3971Reads

41Profile Views

Giant-cell arteritis associated with myelodysplastic syndrome: French multicenter case control study and literature review.

Autoimmun Rev 2020 Feb 13;19(2):102446. Epub 2019 Dec 13.

Department of Internal Medicine, Inflammation-Immunopathology-Biotherapy Department (DHU i2B), Assistance Publique-Hôpitaux de Paris, Hôpital Saint-Antoine, 184, rue du Faubourg Saint-Antoine, 75012 Paris, France Sorbonne Université, France; Sorbonne Universités, INSERM U938, Centre de Recherche Saint-Antoine (CRSA), Paris, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.autrev.2019.102446DOI Listing
February 2020

Luspatercept in Patients with Lower-Risk Myelodysplastic Syndromes.

N Engl J Med 2020 01;382(2):140-151

From Service d'Hématologie Séniors, Hôpital Saint-Louis, Assistance Publique-Hôpitaux de Paris and Université Paris 7, Paris (P.F., L.A.), Service des Maladies du Sang, Hôpital Huriez, Centre Hospitalier Universitaire (CHU) de Lille, Lille (B.Q.), the Department of Internal Medicine, CHU Toulouse, Institut Universitaire du Cancer de Toulouse, Toulouse (O.B.-R.), and Université Cote d'Azur, Département d'Hématologie Clinique, CHU Nice, Nice (T.C.) - all in France; Medical Clinic and Policlinic 1, Hematology and Cellular Therapy, Leipzig University Hospital, Leipzig (U.P.), Klinik für Hämatologie, Onkologie, and Klinische Immunologie, Universitätsklinik Düsseldorf, Düsseldorf (U.G.), and Klinik und Poliklinik für Innere Medizin III, Technische Universität München, Munich (K.S.G.) - all in Germany; the Department of Haemato-Oncology, King's College London, London (G.J.M.), Radcliffe Department of Medicine, University of Oxford, John Radcliffe Hospital, Oxford (P.V.), and the Department of Haematology, Leeds Teaching Hospitals NHS Trust, Leeds (D.B.) - all in the United Kingdom; the Department of Leukemia, University of Texas M.D. Anderson Cancer Center, Houston (G.G.-M.); Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto (R.B.); MDS Unit, Azienda Ospedaliero Universitaria Careggi, University of Florence, Florence (V.S.), the Department of Oncology and Hematology, S. Orsola-Malpighi University Hospital, Bologna (C.F.), the University of Pavia, Fondazione IRCCS Policlinico S. Matteo, Pavia (M.C.), the Hematology Unit, Santi Antonio e Biagio e Cesare Arrigo Hospital, Alessandria (F.S., V.G.), and Dipartimento Biomedicina e Prevenzione, University of Rome Tor Vergata, Rome (M.-T.V.) - all in Italy; the Hematology Department, University Hospital of Salamanca, Institute of Biomedical Research of Salamanca, Salamanca (M.D.-C.), Unidad de Hematología, Hospital Universitario Virgen del Rocío, Seville (J.F.F.), and the Department of Hematology, Hospital Universitario Cruces, Vizcaya (B.A.) - all in Spain; the Department of Hematology Science, School of Medicine, Ankara University, Ankara, Turkey (O.I.); the Department of Hematology and Medical Oncology, Cleveland Clinic, Cleveland (M.A.S.); the Department of Hematology, Algemeen Ziekenhuis Sint-Jan, Bruges (D.S.), and Universitair Ziekenhuis Gent, Ghent (D.M.) - both in Belgium; the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore (A.E.D.); the Division of Hematology-Oncology, Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center (J.G.J.), and Albert Einstein College of Medicine (A.V.) - both in New York; the Department of Hematology, University Medical Center of Groningen, University of Groningen, Groningen, the Netherlands (E.V.); Stanford University Cancer Center, Stanford, CA (P.L.G.); the Center for Hematology and Regenerative Medicine, Department of Medicine, Karolinska Institutet, Stockholm (E.H.-L.); the Department of Internal Medicine, Yale School of Medicine, Yale University, New Haven, CT (A.M.Z.); Vanderbilt University School of Medicine, Vanderbilt-Ingram Cancer Center, Nashville (M.R.S.); Celgene, Summit, NJ (A.L., J.Z., A.R., D.R.D.); Celgene International, Boudry, Switzerland (A.B.); Acceleron Pharma, Cambridge, MA (P.G.L., M.L.S.); and Moffitt Cancer Center, Tampa, FL (R.S.K., A.F.L.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1908892DOI Listing
January 2020

BET inhibitors impair leukemic stem cell function only in defined oncogenic subgroups of acute myeloid leukaemias.

Leuk Res 2019 Dec 7;87:106269. Epub 2019 Nov 7.

INSERM/CNRS UMR 944/7212, Paris, France; Institut Universitaire d'Hématologie, Université Paris Diderot, Sorbonne Paris Cité, Paris Cancer Research Institute (PACRI), Paris, France; Département d'Hématologie, Hôpital Saint-Louis, Assistance Publique - Hopitaux de Paris, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.leukres.2019.106269DOI Listing
December 2019

Autoantibodies in myelodysplastic syndromes and chronic myelomonocytic leukemia.

Leuk Lymphoma 2019 Oct 8;60(10):2594-2596. Epub 2019 Apr 8.

Sorbonne University, Internal Medicine Department, Saint Antoine Hospital , Paris , France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10428194.2019.1599114DOI Listing
October 2019

Non-allogeneic immunotherapy in acute myeloid leukaemia.

Lancet Haematol 2019 09 7;6(9):e443-e444. Epub 2019 Aug 7.

Hôpital Saint Louis, Assistance publique Hôpitaux de Paris, Paris, France; Université de Paris, Paris, France; INSERM U944, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S2352-3026(19)30159-0DOI Listing
September 2019

How we manage adults with myelodysplastic syndrome.

Br J Haematol 2019 Sep 30. Epub 2019 Sep 30.

service d'hématologie séniors, hôpital St Louis, assistance publique - hôpitaux de Paris (APHP) and Université de Paris, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.16206DOI Listing
September 2019

Guadecitabine in myelodysplastic syndromes: promising but there is still progress to be made.

Lancet Haematol 2019 06 3;6(6):e290-e291. Epub 2019 May 3.

Hopital Saint Louis and INSERM U944, 75010 Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S2352-3026(19)30079-1DOI Listing
June 2019

Inflammatory disorders associated with trisomy 8-myelodysplastic syndromes: French retrospective case-control study.

Eur J Haematol 2019 Jan 14;102(1):63-69. Epub 2018 Nov 14.

Department of Internal Medicine, Inflammation-Immunopathology-Biotherapy Department (DHU i2B), Assistance Publique-Hôpitaux de Paris, Hôpital Saint-Antoine, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/ejh.13174DOI Listing
January 2019

An update on treatment of higher risk myelodysplastic syndromes.

Expert Rev Hematol 2019 Jan 18;12(1):61-70. Epub 2018 Dec 18.

a Service Hématologie Séniors, Hôpital Saint Louis , Université Paris Diderot, Assistance Publique-Hôpitaux de Paris , Paris , France.

View Article

Download full-text PDF

Source
https://www.tandfonline.com/doi/full/10.1080/17474086.2018.1
Publisher Site
http://dx.doi.org/10.1080/17474086.2018.1537777DOI Listing
January 2019

Autoimmune manifestations associated with myelodysplastic syndromes.

Ann Hematol 2018 Nov 8;97(11):2015-2023. Epub 2018 Aug 8.

Department of Internal Medicine, Inflammation-Immunopathology-Biotherapy Department (DHU i2B), Assistance Publique - Hôpitaux de Paris, Hôpital Saint-Antoine, 184, rue du Faubourg Saint-Antoine, 75012, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00277-018-3472-9DOI Listing
November 2018

Dual origin of relapses in retinoic-acid resistant acute promyelocytic leukemia.

Nat Commun 2018 05 24;9(1):2047. Epub 2018 May 24.

INSERM U944, Equipe Labellisée par la Ligue Nationale contre le Cancer, Institut Universitaire d'Hématologie (IUH), 75010, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41467-018-04384-5DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5967331PMC
May 2018

Favorable evolution of lung interstitial disease in a patient with chronic myelomonocytic leukemia treated with azacitidine.

Ann Hematol 2018 Mar 23;97(3):541-542. Epub 2017 Nov 23.

Hopital Saint Louis and Paris 7 university, 1 avenue Claude Vellefaux, 75010, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00277-017-3190-8DOI Listing
March 2018

Assessment of Minimal Residual Disease in Standard-Risk AML.

N Engl J Med 2016 08;375(6):e9

Hôpital Saint Louis, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMc1603847DOI Listing
August 2016

Comparison of TP53 mutations screening by functional assay of separated allele in yeast and next-generation sequencing in myelodysplastic syndromes.

Leuk Res 2015 Jul 4. Epub 2015 Jul 4.

Molecular Oncology Unit, Department of Biochemistry, Hospital Saint Louis, AP-HP, Paris, France; Univ Paris Diderot, Sorbonne Paris Cité, CNRS UMR7212/INSERM U944, Paris, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.leukres.2015.07.001DOI Listing
July 2015

Aging and malignant hemopathies.

Haematologica 2015 May;100(5):571-4

Department of Internal Medicine (Hematology and Oncology), University Hospital Cologne, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3324/haematol.2014.117721DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4420205PMC
May 2015

Prognostic value of TP53 gene mutations in myelodysplastic syndromes and acute myeloid leukemia treated with azacitidine.

Leuk Res 2014 Jul 23;38(7):751-5. Epub 2014 Mar 23.

Department of Hematology, Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpital Saint Louis, Université Paris 7, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.leukres.2014.03.012DOI Listing
July 2014

Myelodysplastic syndromes.

Lancet 2014 Jun 21;383(9936):2239-52. Epub 2014 Mar 21.

Service d'hématologie, Hôpital St Louis (Assistance Publique Hôpitaux de Paris) and Paris 7 University, Paris, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S0140-6736(13)61901-7DOI Listing
June 2014

Tc1 clonal T cell expansion during chronic graft-versus-host disease-associated hypereosinophilia.

Biol Blood Marrow Transplant 2014 May 24;20(5):739-42. Epub 2014 Jan 24.

Departement d'Immunologie, INSERM UMRS-940, Paris, France; Université Paris Diderot, Sorbonne Paris Cité, Paris, France; Service d'Hématologie-Greffe, AP-HP Hôpital Saint Louis, Paris, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2014.01.023DOI Listing
May 2014

Management and treatment results in patients with acute promyelocytic leukaemia (APL) not enrolled in clinical trials.

Eur J Cancer 2014 Apr 15;50(6):1159-68. Epub 2014 Jan 15.

Department of Hematology and EA3518, Hôpital Saint-Louis (Assistance Publique - Hôpitaux de Paris), University Paris Diderot, Paris, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejca.2013.11.023DOI Listing
April 2014

Hypomethylating agents and chemotherapy in MDS.

Best Pract Res Clin Haematol 2013 Dec 7;26(4):411-9. Epub 2013 Oct 7.

Hematology, AOU Careggi, University of Florence, Largo Brambilla 3, Florence, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.beha.2013.09.010DOI Listing
December 2013

How we treat lower-risk myelodysplastic syndromes.

Blood 2013 May 10;121(21):4280-6. Epub 2013 Apr 10.

Hôpital Avicenne-Service d'Hématologie Clinique and Paris 13 University, Bobigny, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2013-02-453068DOI Listing
May 2013

Incidence of 17p deletions and TP53 mutation in myelodysplastic syndrome and acute myeloid leukemia with 5q deletion.

Genes Chromosomes Cancer 2012 Dec 30;51(12):1086-92. Epub 2012 Aug 30.

Laboratoire d'Hématologie, Hôpital Avicenne, Assistance Publique-Hôpitaux de Paris (AP-HP)/Université Paris 13, Bobigny. France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/gcc.21993DOI Listing
December 2012

Treatment of advanced myelodysplastic syndrome with demethylating agents: azacitidine.

Semin Hematol 2012 Oct;49(4):323-9

Hôpital Avicenne, Assistance Publique-Hôpitaux de Paris, Service d'hématologie clinique, Paris 13 university, Bobigny, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.seminhematol.2012.09.002DOI Listing
October 2012

Immunomodulating drugs in myelodysplastic syndromes.

Hematology Am Soc Hematol Educ Program 2011 ;2011:556-60

Hôpital Avicenne, Assistance Publique-Hôpitaux de Paris, Paris, France.

View Article

Download full-text PDF

Source
http://www.zums.ac.ir/files/research/site/medical/Hematology
Web Search
http://www.asheducationbook.org/cgi/doi/10.1182/asheducation
Publisher Site
http://dx.doi.org/10.1182/asheducation-2011.1.556DOI Listing
April 2012

[The 5q- syndrome].

Rev Prat 2010 Dec;60(10):1420-2

Service d'hématologie clinique, hôpital Avicenne, AP-HP, université Paris-13, 93009 Bobigny Cedex.

View Article

Download full-text PDF

Source
December 2010